Seikagaku Corporation (TYO:4548)

Market Cap	39.70B +10.9%
Revenue (ttm)	36.65B -6.9%
Net Income	1.47B +21.3%
EPS	26.98 +21.3%
Shares Out	54.60M
PE Ratio	26.95
Forward PE	n/a
Dividend	30.00 (4.13%)
Ex-Dividend Date	Sep 29, 2026

Volume	311,700
Open	705.00
Previous Close	727.00
Day's Range	692.00 - 705.00
52-Week Range	632.00 - 820.00
Beta	0.22
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 5, 2026

About Seikagaku

Seikagaku Corporation manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally. It operates in two segments, Pharmaceuticals and LAL Business. The company offers pharmaceuticals and medical devices, including intra-articular injections for improving joint functions under the ARTZ, ARTZ Dispo, VISCO-3, JOYCLU, Gel-One, Hylink, and SUPARTZ brands; ophthalmic surgical aids under the OPEGAN and SHELLGAN brand names; surgical aids for endoscopic mucosal resection under the brand nam...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1947
• Employees: 1,142
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4548

Financial Performance

In fiscal year 2026, Seikagaku's revenue was 36.65 billion, a decrease of -6.93% compared to the previous year's 39.37 billion. Earnings were 1.47 billion, an increase of 21.33%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 6, 2026

Data Sources Report a data error